MENU
OCT 1, 2020

Changing the Precision Oncology Research Paradigm with Genexus

With traditional NGS, long turnaround times (TAT) of 4+ weeks and high failure rates due to quantity not sufficient (QNS) are common. The Ion Torrent™ Genexus™ System is a better testing solution: it decreases TAT to as little as 1 day from sample to results,* and essentially eliminates QNS failure, achieving success using tissue samples as small as 10 ng. Join us to learn how the Genexus System can improve your lab’s efficiency and increase your testing success rates.

 

By the conclusion of this session you will understand:

  • A pathologist’s perspective on the importance of in-house NGS testing for precision oncology research
  • The importance of getting results as fast as possible for the maximum number of samples
  • Benefits of the Genexus System in a post‑pandemic laboratory
  • Financial and operational impacts of the Genexus System for in-house genomic profiling

 

Learning Objectives:

     1. Understand the value of the Genexus in a post-pandemic environment

     2. Explore the financial & operational impacts of the Ion Torrent Genexus™ System for in-house

         genomic profiling


This virtual meeting will be conducted within OncomineWorld in our virtual auditorium. OncomineWorld is so much more than your traditional virtual event – you can navigate to many different areas and experience a new level of virtual interactivity. Within OncomineWorld you can…

  • Explore the NGS Oncology Application Hall and its many specialty booth-labs including immuno-oncology research, emerging NSCLC biomarkers, liquid biopsy, PIK3Ca research testing, and hemato-oncology research
  • Visit our virtual lab to experience the new world of easy and fast NGS - the Ion Torrent Genexus System - and become familiar with our well-proven workhorse, the Ion Torrent GeneStudio system, with its many applications
  • Earn continuing education (CE) credits by listening to 12 educational talks from leading NGS users on topics such as comprehensive genomic profiling (CGP), the future of precision oncology biomarkers testing in the routine clinical space, personal experiences with different NGS products and solutions, and much more
  • Visit the Precision Oncology Hall to access videos, posters and more on the future potential of NGS in the clinic
  • See the latest research by Thermo Fisher Scientific in the Poster Hall.

 

* Specimen-to-report workflow will be available after the Ion Torrent™ Genexus™ Purification System and integrated reporting capabilities are added in 2021.


Speakers
  • Vice President of Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific
  • Associate Director, Cytogenetics & Molecular Pathology Laboratories - Department of Pathology & Laboratory Medicine - Cedars-Sinai Medical Center
  • Director of Molecular Pathology, Cedars-Sinai Medical Center

Show Resources
You May Also Like
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT - SESSIONS WILL BE AVAILABLE FOR ON-DEMAND VIEWING IMMEDIATELY FOLLOWING THE LIVE BROADCAST.
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
OCT 28, 2020 7:00 AM GMT, 12:30PM IST, 3:00PM SGT - SESSIONS WILL BE AVAILABLE FOR ON-DEMAND VIEWING IMMEDIATELY FOLLOWING THE LIVE BROADCAST.
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Each step in a diagnostic test's journey-from raw material extraction to patient administration-can influence outcomes....
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Please join us for this FREE workshop, as we present Agilent’s LC/MS hardware and software solutions for getting the most out of your analysis data....
NOV 10, 2020 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 10, 2020 8:00 AM EST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Join us for presentations by scientists from leading labs in immuno-oncology, drug discovery, cell line development, and 3D/PDO models. Learn how to conduct modern cell-based assays with var...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
NOV 01, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 01, 2020
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
The ICIS Annual Meetings typically attract 650-750 registrants and have a distinguished history of presenting cutting edge research from internationally recognized scientists. This meeting e...
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
Agenda
  • Financial and operational impact of implementing the Genexus System in our laboratory
    OCT 01, 2020 12:20 PM CST
    Financial and operational impact of implementing the Genexus System in our laboratory
    Kevin Kawachi, MPH, CLS, SI(ASCP)
    Associate Director, Cytogenetics & Molecular Pathology Laboratories - Department of Pathology & Laboratory Medicine - Cedars-Sinai Medical Center
  • Experience the New World of Easy NGS with Genexus
    OCT 01, 2020 11:45 AM CST
    Experience the New World of Easy NGS with Genexus
    Andy Felton, PhD
    Vice President of Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific
  • NGS hurdles that can be overcome with rapid turnaround time
    OCT 01, 2020 11:10 AM CST
    NGS hurdles that can be overcome with rapid turnaround time
    Eric Vail, MD
    Director of Molecular Pathology, Cedars-Sinai Medical Center
  • Introductions
    OCT 01, 2020 11:00 AM CST
    Introductions
Speakers

  • Andy Felton, PhD
    Vice President of Product Management, Clinical Next Generation Sequencing, Thermo Fisher Scientific
    Biography

      Andy is currently the Vice President of Product Management and Market Development for the Clinical Sequencing Division, responsible for the development and launch of all products related to Ion Torrent NGS systems. Andy began his career at Applied Biosystems, UK team in 1994 after completing an undergraduate degree in Chemistry at Liverpool (JM) University and a PhD focused on peptide fragments of Epidermal Growth Factor at Oxford Brooks University. In 1997 he moved to corporate headquarters in California and entered Product Management. During this time Andy was responsible for a number of product lines and launches, including the launch of the 7300/7500 and 7500 Fast Real Time PCR Systems, and the 3500 and 3500 Dx Genetic Analyzers, eventually becoming the Director of the Capillary Electrophoresis business. Andy joined Ion Torrent in June 2010 during its start-up phase and subsequent purchase by Life Technologies.

    • Kevin Kawachi, MPH, CLS, SI(ASCP)
      Associate Director, Cytogenetics & Molecular Pathology Laboratories - Department of Pathology & Laboratory Medicine - Cedars-Sinai Medical Center
      Biography

        Kevin is currently the Associate Director of the Molecular Pathology and Cytogenetics laboratories at Cedars-Sinai Medical Center, Department of Pathology & Laboratory Medicine. Kevin has worked at Cedars-Sinai for more that thirty years as a Clinical Laboratory Scientist. He has a Specialist Certification in Immunology from the ASAP and received his Master's in Public Health from UCLA. Kevin has been involved with molecular testing for more than 20 years. His current role is to oversee operations and testing in the Molecular Pathology and Cytogenetics laboratories.

      • Eric Vail, MD
        Director of Molecular Pathology, Cedars-Sinai Medical Center
        Biography

          Dr. Vail is currently the Director of Molecular Pathology at Cedars-Sinai Medical Center, responsible for the administration, development and validation of all clinical molecular diagnostics at CSMC. Dr. Vail recived his MD from St. George's University. In 2017 he completed his AP/CP residency at New York Medical College and subsequently finished a Molecular Genetic Pathology fellowship at CSMC. Dr. Vail's primary research focus is in the utilization of clinical sequencing in cancer and (more recently) the local genomics of SARS-CoV-2.

        C.E. Credits

        The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


        Help

        General LabRoots Questions

        email support@labroots.com  

        Virtual Events and Webinars

        Supported Configurations

        • Operating System Internet Explorer Firefox Chrome Safari
          Vista IE8+ FF10+ Chrome15+
          Windows 7 IE8+ FF10+ Chrome15+
          Windows 8 IE10 FF10+ Chrome15+
          Mac OS X   FF10+ Chrome15+ Safari5.1+
        • Cookie settings: session cookies enabled
        • Browser configuration must have JavaScript enabled
        • Adobe Flash player 10.2 or later

        To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

        Internet Connection

        • A minimum of 100Kbps is recommended for audio-only events
        • A minimum of 300Kbps is recommended for speaker on-video events

        Computer Equipment

        • Screen Resolution: Minimum 1024x768
        • Video Card: 65,000 colors minimum
        • Sound card and speakers (or headphones) for hearing webcast in full format
        • Audio Card: 16-bit minimum
        • RAM: 512MB of free RAM

        Firewall Protocol

        • HTTP on port 80 or HTTPS on port 443
        • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
        • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

        Work-At-Home Attendees

        • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

        For A Seamless Experience

        When using a mobile device, FREE Mobile Apps are available:

        - For viewing Webinars:

        - For viewing Virtual Events

        Attendee Guide

        • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

        Virtual Event and Webinar Support:

        Continuing Education (CME/CE) Support

        Loading Comments...
        Show Resources
        Attendees
        • See more